Ahmad Alenezi: Harrison.ai Secured Its 13th FDA Clearance, And This One Is a Literal Life-Saver
Ahmad Alenezi, Nuclear Medicine Technology Specialist, Assistant Professor at Kuwait University, shared on LinkedIn:
”Big news for the stroke care community!
Harrison.ai just secured its 13th FDA clearance, and this one is a literal life-saver.
They have developed the first AI cleared to triage acute ischemic stroke (tissue injury) on a patient’s very first non-contrast CT scan.
Why this matters?:
In stroke care, ‘time is brain.’
Traditionally, AI needed a second, more complex scan (CTA) to flag a blockage.
By catching signs of injury on the initial ER scan, we’re cutting down the ‘door-to-needle’ time when every second counts toward a patient’s recovery.
This isn’t just about faster tech, it’s about getting clinicians the right data earlier to prevent permanent disability.
Huge win for the team and a massive step forward for emergency radiology.
Those milestones and developments necessitate the integration of AI medical education in our syllabus.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding
-
Nov 17, 2026, 14:54Cindy Neunert: Beyond Platelet Counts – Addressing Fatigue and Whole-Person Care in ITP
-
Nov 17, 2026, 14:44Strengthening Haemophilia Diagnosis Through Hands-On Laboratory Training – IAHAD
-
Nov 17, 2026, 14:40Platelet Membrane Protrusions Beyond Their Role in Hemostasis – JTH
-
Nov 17, 2026, 14:10Wolfgang Miesbach: Aspirin vs Anticoagulants – Who Needs More Than Aspirin?
-
Nov 17, 2026, 14:08Chaza Alaji: Soluble Transferrin Receptor – A Key to Uncovering Hidden Iron Deficiency
-
Nov 17, 2026, 14:03Shadi Tabibian: Fibrinogen – From Molecular Structure to Clinical Decision Making
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome